<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787163</url>
  </required_header>
  <id_info>
    <org_study_id>Amnioinfusion-001</org_study_id>
    <nct_id>NCT00787163</nct_id>
  </id_info>
  <brief_title>Amnioinfusion Initiative</brief_title>
  <official_title>Open Randomized Trial Comparing Perinatal Outcome Following Expectant Management Versus Amnioinfusion in PPROM &lt;25 Wks With Persistent Oligohydramnios</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catholic University, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare perinatal survival in patients presenting with early
      spontaneous PPROM and persistent oligohydramnios, managed either conservatively or with
      serial amnioinfusions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early spontaneous Preterm Premature Rupture of Membranes (PPROM) is associated with high
      perinatal mortality. Due to pulmonary hypoplasia and preterm delivery, mortality exceeds 60%
      when PPROM occurs prior to 24 weeks. When oligohydramnios persists, it may raise to 90%.
      Morbidity in survivors is also significant. In uncontrolled series, serial amnioinfusions,
      which have acceptable invasiveness and are of limited complexity, mortality was reduced to
      60%.

      We propose an open, multicenter randomized trial comparing perinatal survival in patients
      presenting with early spontaneous PPROM and persistent oligohydramnios, managed either
      conservatively or with serial amnioinfusions. Inclusion criteria: Single pregnancy, early
      spontaneous PPROM &lt; 24.3 weeks, oligohydramnios (deepest vertical pocket &lt; 2 cm) for at least
      4 days and no longer than 15 days at enrolment. The study is open and will be run through a
      dedicated password protected web site, and with a minimal number of outcome measures. Primary
      outcome: Survival till discharge from the NICU. Secondary outcomes: Latency time from PPROM
      to delivery, gestational age at birth, indication for delivery, number of days of ventilatory
      support, serious neurologic morbidity, neonatal sepsis prevalence, need for oxygen at 36
      weeks post-conception.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of neonates/infants at discharge after serial amnioinfusions compared to survival after expectant management</measure>
    <time_frame>discharge of every neonate from NICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age of delivery (main secondary outcome)</measure>
    <time_frame>time of delivery for every case</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Oligohydramnios</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>amnioinfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>expectant management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>amnioinfusion</intervention_name>
    <description>serial amnioinfusions aimed at restoring amniotic fluid volume</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients above 18 years, who are able to consent, with

          2. Singleton pregnancy

          3. with a normal structural examination as much as possible;

          4. At least 2 US examination after pPROM for gestational age confirmation and diagnosis
             of persistent oligohydramnios

          5. Follow up ultrasound examinations weekly in the treatment group

          6. Acceptance of randomisation and to comply with the protocol

        Exclusion Criteria:

          1. Maternal contra-indications to intervention or prolongation of pregnancy, including
             severe medical conditions in pregnancy that make fetal intervention riskful;

          2. Preterm labour defined as contractions &gt;6/hour associated with cervical changes,
             cervix shortened (&lt;15 mm at randomization),

          3. Cervical cerclage in place

          4. Chorioamnionitis, defined as 2 or more of the following: maternal temperature&gt;38
             degrees, foul-smelling vaginal discharge, uterine tenderness, fetal tachycardia&gt;170
             bpm, white blood cell count &gt;18,000

          5. Fetal structural anomaly detected at prenatal ultrasonography, or fetal chromosomal
             abnormalities involving autosomes

          6. Previous invasive procedure in this index pregnancy

          7. Fetal condition mandating immediate delivery

          8. Severe bleeding

          9. Maternal HIV and HCV infection

         10. Multiple gestation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Locatelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milano Bicocca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrizia Vergani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Milano Bicocca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Locatelli, MD</last_name>
    <phone>+39 039 233 4720</phone>
    <email>anna.locatelli@unimib.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Milano Bicocca, Ospedale san Gerardo Monza</name>
      <address>
        <city>Monza</city>
        <state>Milano</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Locatelli, MD</last_name>
      <phone>+390392334720</phone>
      <email>anna.locatelli@unimib.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2008</study_first_posted>
  <last_update_submitted>January 21, 2009</last_update_submitted>
  <last_update_submitted_qc>January 21, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>Anna Locatelli</name_title>
    <organization>University of Milano Bicocca</organization>
  </responsible_party>
  <keyword>pPROM</keyword>
  <keyword>oligohydramnios</keyword>
  <keyword>amnioinfusion</keyword>
  <keyword>prematurity</keyword>
  <keyword>Early premature rupture of membranes in pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oligohydramnios</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

